Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.49 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | TTR | P02766 | 2/20 | 0.49 |
| ▸ | FABP2 | P12104 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30216000 | 1.00 | MEN1 (0.49) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| SCHEMBL18561607 | 0.96 | MEN1 (0.50) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| Ethylene SCHEMBL27852304 | 0.96 | MEN1 (0.46) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| SCHEMBL18430879 | 0.94 | MEN1 (0.53) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| Chloromethane SCHEMBL27622109 | 0.94 | MEN1 (0.49) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| SCHEMBL16673243 | 0.94 | MEN1 (0.49) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| Sulfur Dioxide SCHEMBL28061237 | 0.92 | MEN1 (0.47) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| SCHEMBL2238426 | 0.88 | PTGES2 (0.46) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| SCHEMBL9057929 | 0.85 | ALDH1A1 (0.52) | MEN1PTGS1KMT2APTGS2SLC22A6 | |
| SCHEMBL18716177 | 0.85 | CYP2C9 (0.47) | MEN1PTGS1KMT2APTGS2SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240339730-A1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-10-10 | — | — | US | claimed |
| EP-4411963-A2 | ELECTROCHEMICAL DEVICE | Ningde Amperex Technology Ltd. (CN) | 2024-08-07 | — | — | EP | claimed |
| US-12057602-B2 | Electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-08-06 | — | — | US | claimed |
| EP-3966880-B1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2024-07-31 | — | — | EP | claimed |
| CN-117976982-A | Sodium ion battery electrolyte, preparation method thereof and sodium ion battery | 桂林电子科技大学 | 2024-05-03 | — | — | CN | claimed |
| CN-117954685-A | Flame-retardant electrolyte and lithium ion battery using same | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-114605289-B | Carbamate compound for nonaqueous electrolyte and application thereof | 湖州师范学院 | 2023-11-17 | — | — | CN | claimed |
| CN-112010894-B | Phosphorothioate compound, nonaqueous lithium ion battery electrolyte containing phosphorothioate compound and lithium ion battery | 湖州师范学院 | 2023-08-11 | — | — | CN | claimed |
| US-20230198096-A1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-06-22 | — | — | US | claimed |
| US-11637319-B2 | Electrolytic solution and electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-04-25 | — | — | US | claimed |
| CN-110408411-A | Liquid-crystal composition and application thereof and liquid crystal display element | JNC CORP | 2019-11-05 | — | — | CN | claimed |
| US-7304065-B2 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2007-12-04 | — | — | US | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| US-5142093-A | Process for the preparation of 4-(2,4-difluorophenyl)-phenyl 4-nitro-benzoate | ZAMBON GROUP S.P.A. (IT) | 1992-08-25 | — | — | US | claimed |
| EP-0180290-B1 | OMEGA-(2',4'-DIHALOBIPHENYLYL)OXO ALKANOIC ACIDS AND PROCESS FOR THEIR PREPARATION | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) | 1987-10-28 | — | — | EP | claimed |
| EP-0126287-B1 | FLUORINATED COMPOUNDS HAVING ANALGESIC AND ANTIINFLAMMATORY ACTIVITIES | MEDEA RESEARCH S.r.l. (IT) | 1987-06-16 | — | — | EP | claimed |
| EP-0180290-A1 | Omega-(2',4'-dihalobiphenylyl)oxo alkanoic acids and process for their preparation | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) | 1986-05-07 | — | — | EP | claimed |
| EP-0126287-A1 | Fluorinated compounds having analgesic and antiinflammatory activities | MEDEA RESEARCH S.r.l. (IT) | 1984-11-28 | — | — | EP | claimed |
| US-4225730-A | Process for preparing 4-(2,4-difluorophenyl)-salicyclic acid | MERCK & CO., INC. (US) | 1980-09-30 | — | — | US | claimed |
| US-3992459-A | BIARYL COUPLING BY DIAZOTIZATION | MERCK & CO., INC. (US) | 1976-11-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | MEN1 238/4885PTGS1 2265/4885KMT2A 2516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.